Literature DB >> 16628555

Allogeneic bone marrow transplantation with reduced intensity conditioning for chronic granulomatous disease complicated by invasive Aspergillus infection.

Jairam Sastry1, Alyson Kakakios, Heidi Tugwell, Peter J Shaw.   

Abstract

Chronic granulomatous disease (CGD) is a rare disorder characterized by recurrent infections, often resulting in impaired quality of life and death. Allogeneic BMT provides a definitive cure for CGD, but carries a significant risk of mortality and morbidity. The risk is higher for those who have invasive fungal infection prior to transplant. Reduced intensity conditioning (RIC) is associated with less toxicity from the conditioning agents and may provide an alternative option for all non-malignant diseases. We report a case of successful allogeneic BMT after RIC for a case of X-linked CGD complicated by severe invasive aspergillosis (IA).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16628555     DOI: 10.1002/pbc.20865

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  6 in total

Review 1.  Chronic granulomatous disease: overview and hematopoietic stem cell transplantation.

Authors:  Elizabeth M Kang; Betty E Marciano; SukSee DeRavin; Kol A Zarember; Steven M Holland; Harry L Malech
Journal:  J Allergy Clin Immunol       Date:  2011-04-17       Impact factor: 10.793

2.  Successful allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease with inflammatory complications and severe infection.

Authors:  Keisuke Kato; Yasuko Kojima; Chie Kobayashi; Kazumasa Mitsui; Ryoko Nakajima-Yamaguchi; Kazuko Kudo; Toshihiro Yanai; Ai Yoshimi; Tomohei Nakao; Tomohiro Morio; Mureo Kasahara; Kazutoshi Koike; Masahiro Tsuchida
Journal:  Int J Hematol       Date:  2011-10-21       Impact factor: 2.490

3.  Advances in treatment for chronic granulomatous disease.

Authors:  Elizabeth M Kang; Harry L Malech
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

4.  Successful treatment of chronic granulomatous disease with fludarabine-based reduced-intensity conditioning and unrelated bone marrow transplantation.

Authors:  Daiichiro Hasegawa; Masako Fukushima; Yuki Hosokawa; Hiroki Takeda; Keiichiro Kawasaki; Tomoyuki Mizukami; Hiroyuki Nunoi; Hiroshi Ochiai; Tomohiro Morio; Yoshiyuki Kosaka
Journal:  Int J Hematol       Date:  2007-12-07       Impact factor: 2.490

5.  The first rare and fatal case of invasive aspergillosis of spinal cord due to Aspergillus nidulans in an Iranian child with chronic granulomatosis disease: review of literature.

Authors:  Mahin Tavakoli; Mohammad Taghi Hedayati; Hossein Mirhendi; Sadegh Nouripour-Sisakht; Newsha Hedayati; Fatemeh Saghafi; Setareh Mamishi
Journal:  Curr Med Mycol       Date:  2020

Review 6.  Genetics and immunopathology of chronic granulomatous disease.

Authors:  Marie José Stasia; Xing Jun Li
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.